Navigation auf



Congratulations to the ITINERARE Grants winners!

ITINERARE has launched its first call for proposals for research grants that will provide bridging funding to ongoing projects involving researchers affiliated to the ITINERARE consortium. Four grants of the duration of 24 months (January 2022 – December 2023) have been awarded to projects that are in line with the mission of ITINERARE to foster interdisciplinary translational research in the field of rare disease.

Congratulations to the winners!


Dr. Desirée Böck
(affiliated to Prof. Schwank group)

Project: therapeutic use of CRISPR/Cas9 base editing for the treatment of Vanishing White Matter Disease


Dr. Sean Froese
(affiliated to Prof. Baumgartner group)

Project: epigenetic changes in remethylation disorders: a novel target


Dr. Alessandro Luciani
(affiliated to Prof. Devuyst group)

Project: an integrated drug discovery strategy for rare endolysosomal disorders


Dr. Sebastian Wäscher
(affiliated to Prof. Biller-Andorno group)

Project: bridging the gap between stakeholders in rare disease health care. A qualitative focus group study